We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Plug Power
PLUG
$1.9B
| $406 | ﹤0.01% |
150
| – | – |
2021 Q2
20 quarters
|
|
527
Corbus Pharmaceuticals
CRBP
$81.6M
| $384 | ﹤0.01% |
41
| – | – |
2020 Q1
25 quarters
|
|
528
Aldeyra Therapeutics
ALDX
$33.8M
| $330 | ﹤0.01% |
155
| – | – |
2021 Q1
21 quarters
|
|
529
State Street Financial Select Sector SPDR ETF
XLF
$52.7B
| $321 | ﹤0.01% |
6
| – | – |
2025 Q4
2 quarters
|
|
530
Brighthouse Financial
BHF
$2.53B
| $316 | ﹤0.01% |
5
| – | – |
2025 Q2
4 quarters
|
|
531
Quantum Cyber N.V.
QUCY
$70.6M
| $314 | ﹤0.01% |
200
| – | – |
2025 Q4
2 quarters
|
|
532
Knightscope
KSCP
$11M
| $293 | ﹤0.01% |
139
| – | – |
2025 Q1
5 quarters
|
|
533
Lite Strategy Inc
LITS
$34.1M
| $264 | ﹤0.01% |
287
| – | – |
2020 Q3
23 quarters
|
|
534
Celularity
CELU
$26M
| $263 | ﹤0.01% |
441
| – | – |
2022 Q1
17 quarters
|
|
535
Ciena
CIEN
$45.5B
| – | – |
0
| – | – |
2026 Q1
1 quarter
|
|
536
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.9B
| $220 | ﹤0.01% |
5
| – | – |
2021 Q1
21 quarters
|
|
537
Fidelity Disruptive Finance ETF
FDFF
$42.5M
| $201 | ﹤0.01% |
6
| – | – |
2025 Q2
4 quarters
|
|
538
Lumen Technologies, Inc. Common Stock
LUMN
$5.03B
| $192 | ﹤0.01% |
25
| – | – |
2025 Q2
4 quarters
|
|
539
FF EAI Robotics Ecosystem Inc. Common Stock
FFR
$28M
| $188 | ﹤0.01% |
160
| – | – |
2021 Q1
21 quarters
|
|
540
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$18B
| $188 | ﹤0.01% |
4
| – | – |
2021 Q1
21 quarters
|
|
541
Vodafone
VOD
$36.8B
| $185 | ﹤0.01% |
14
| – | – |
2025 Q2
4 quarters
|
|
542
Ulta Beauty
ULTA
$27.4B
| – | – |
0
| – | – |
2024 Q3
7 quarters
|
|
543
Under Armour
UAA
$2.14B
| $134 | ﹤0.01% |
21
| – | – |
2023 Q4
10 quarters
|
|
544
Under Armour Class C
UA
$2.08B
| $130 | ﹤0.01% |
21
| – | – |
2023 Q4
10 quarters
|
|
545
Gemini Space Station
GEMI
$376M
| $127 | ﹤0.01% |
30
| – | – |
2025 Q3
3 quarters
|
|
546
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$48.6B
| $108 | ﹤0.01% |
1
| – | – |
2021 Q1
21 quarters
|
|
547
Blue Gold Ltd
BGL
$5.36M
| $75 | ﹤0.01% |
270
| – | – |
2025 Q3
3 quarters
|
|
548
Kyndryl
KD
$3.01B
| $67 | ﹤0.01% |
6
| – | – |
2025 Q2
4 quarters
|
|
549
ChargePoint
CHPT
$256M
| $65 | ﹤0.01% |
11
| – | – |
2022 Q4
14 quarters
|
|
550
AI Financial Corp
AIFC
$35M
| $58 | ﹤0.01% |
100
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.